Huapont Life Sciences Co.,Ltd. (002004.SZ)
- Previous Close
4.1100 - Open
4.0600 - Bid 4.0900 x --
- Ask 4.1000 x --
- Day's Range
4.0700 - 4.1300 - 52 Week Range
3.6800 - 5.2300 - Volume
13,733,550 - Avg. Volume
22,896,823 - Market Cap (intraday)
8.177B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1400 - Earnings Date --
- Forward Dividend & Yield 0.22 (5.37%)
- Ex-Dividend Date Jun 3, 2024
- 1y Target Est
--
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and ophthalmology, as well as health management products. In addition, the company provides pesticide technical, intermediate and preparation products, and GLP registration technical services. Further, it engages in the research and development, production, and sales of fine chemical products and polymer materials, as well as provides tourism services and agent for the promotion of preparation products. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co.,Ltd. in September 2015. Huapont Life Sciences Co.,Ltd. was founded in 1992 and is headquartered in Chongqing, China.
www.huapont.com.cn--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 002004.SZ
View MorePerformance Overview: 002004.SZ
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002004.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002004.SZ
View MoreValuation Measures
Market Cap
8.14B
Enterprise Value
13.17B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.70
Price/Book (mrq)
0.85
Enterprise Value/Revenue
1.14
Enterprise Value/EBITDA
65.41
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.56%
Return on Assets (ttm)
2.64%
Return on Equity (ttm)
-2.14%
Revenue (ttm)
11.66B
Net Income Avi to Common (ttm)
-298.99M
Diluted EPS (ttm)
-0.1400
Balance Sheet and Cash Flow
Total Cash (mrq)
4.41B
Total Debt/Equity (mrq)
60.03%
Levered Free Cash Flow (ttm)
-1.08B